Heel medicines are available in 50 countries worldwide. Choose your country below to learn more.
Submission for Hans-Heinrich Reckeweg Clinical Case Awards now closedEveryday clinical practice holds invaluable insights about diseases, treatments and patient outcomes. Document your findings and submit a case report to the Hans-Heinrich Reckeweg Clinical Case Award in integrative medicine. The Award is bestowed for excellent clinical case reporting in recognition of the importance of advancing real-world clinical research. It is divided between a main (10,000 EUR) and a runner-up winner (5,000 EUR). Submissions for the Hans-Heinrich Reckeweg Clinical Case Award 2018 are now closed. Read more on the award
Heel is yet again one of the best employers in GermanyBiologische Heilmittel Heel GmbH has received the Top Employer Germany award in 2018 for the ninth time in succession. Heel convinced the jury particularly in the categories of training and development, onboarding and Human Resources planning. More on Heel's honors and awards
Press releaseHeel’s Traumeel® and Zeel® T shown to reduce pain of OA of the knee by more than 60% in MOZArT trial - Clinical data released at the 2015 European League Against Rheumatism (EULAR) congress show Traumeel® and Zeel® T co-administered intra-articular (IA) injections provide a new first line injection treatment option in the management of moderate to severe osteoarthritis of the knee, where oral pain management failed. More press releases